1. Vinik AI. 2016; Clinical practice. Diabetic sensory and motor neuropathy. N Engl J Med. 374:1455–64. DOI:
10.1056/NEJMcp1503948. PMID:
27074068.
4. Morgado C, Terra PP, Tavares I. 2010; Neuronal hyperactivity at the spinal cord and periaqueductal grey during painful diabetic neuropathy: effects of gabapentin. Eur J Pain. 14:693–9. DOI:
10.1016/j.ejpain.2009.11.011. PMID:
20056558.
Article
5. Morgado C, Silva L, Pereira-Terra P, Tavares I. 2011; Changes in serotoninergic and noradrenergic descending pain pathways during painful diabetic neuropathy: the preventive action of IGF1. Neurobiol Dis. 43:275–84. DOI:
10.1016/j.nbd.2011.04.001. PMID:
21515376.
Article
6. Lisi L, Aceto P, Navarra P, Dello Russo C. 2015; mTOR kinase: a possible pharmacological target in the management of chronic pain. Biomed Res Int. 2015:394257. DOI:
10.1155/2015/394257. PMID:
25685786. PMCID:
PMC4313067.
Article
8. Guo JR, Wang H, Jin XJ, Jia DL, Zhou X, Tao Q. 2017; Effect and mechanism of inhibition of PI3K/Akt/mTOR signal pathway on chronic neuropathic pain and spinal microglia in a rat model of chronic constriction injury. Oncotarget. 8:52923–34. DOI:
10.18632/oncotarget.17629. PMID:
28881783. PMCID:
PMC5581082.
Article
9. Price TJ, Rashid MH, Millecamps M, Sanoja R, Entrena JM, Cervero F. 2007; Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR. J Neurosci. 27:13958–67. DOI:
10.1523/JNEUROSCI.4383-07.2007. PMID:
18094233. PMCID:
PMC2206543.
Article
10. Xu Q, Fitzsimmons B, Steinauer J, O'Neill A, Newton AC, Hua XY, et al. 2011; Spinal phosphinositide 3-kinase-Akt-mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesia. J Neurosci. 31:2113–24. DOI:
10.1523/JNEUROSCI.2139-10.2011. PMID:
21307248. PMCID:
PMC3097059.
Article
11. Asante CO, Wallace VC, Dickenson AH. 2009; Formalin-induced behavioural hypersensitivity and neuronal hyperexcitability are mediated by rapid protein synthesis at the spinal level. Mol Pain. 5:27. DOI:
10.1186/1744-8069-5-27. PMID:
19500426. PMCID:
PMC2699332.
Article
13. Li JN, Sheets PL. 2018; The central amygdala to periaqueductal gray pathway comprises intrinsically distinct neurons differentially affected in a model of inflammatory pain. J Physiol. 596:6289–305. DOI:
10.1113/JP276935. PMID:
30281797. PMCID:
PMC6292805.
Article
17. Gwak YS, Hulsebosch CE, Leem JW. 2017; Neuronal-glial interactions maintain chronic neuropathic pain after spinal cord injury. Neural Plast. 2017:2480689. DOI:
10.1155/2017/2480689. PMID:
28951789. PMCID:
PMC5603132.
Article
18. Yang Y, Zhang Z, Guan J, Liu J, Ma P, Gu K, et al. 2016; Administrations of thalidomide into the rostral ventromedial medulla alleviates painful diabetic neuropathy in Zucker diabetic fatty rats. Brain Res Bull. 125:144–51. DOI:
10.1016/j.brainresbull.2016.06.013. PMID:
27346278.
Article
19. Goyal SN, Reddy NM, Patil KR, Nakhate KT, Ojha S, Patil CR, et al. 2016; Challenges and issues with streptozotocin-induced diabetes - a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chem Biol Interact. 244:49–63. DOI:
10.1016/j.cbi.2015.11.032. PMID:
26656244.
Article
20. Swanson LW. 2018; Brain maps 4.0-structure of the rat brain: an open access atlas with global nervous system nomenclature ontology and flatmaps. J Comp Neurol. 526:935–43. DOI:
10.1002/cne.24381. PMID:
29277900. PMCID:
PMC5851017.
Article
25. Tortorici V, Morgan MM. 2002; Comparison of morphine and kainic acid microinjections into identical PAG sites on the activity of RVM neurons. J Neurophysiol. 88:1707–15. DOI:
10.1152/jn.2002.88.4.1707. PMID:
12364500.
Article
26. Guo J, Fu X, Cui X, Fan M. 2015; Contributions of purinergic P2X3 receptors within the midbrain periaqueductal gray to diabetes-induced neuropathic pain. J Physiol Sci. 65:99–104. DOI:
10.1007/s12576-014-0344-5. PMID:
25367719.
Article
27. Zhuang X, Chen Y, Zhuang X, Chen T, Xing T, Wang W, et al. 2016; Contribution of pro-inflammatory cytokine signaling within midbrain periaqueductal gray to pain sensitivity in Parkinson's disease via GABAergic pathway. Front Neurol. 7:104. DOI:
10.3389/fneur.2016.00104. PMID:
27504103. PMCID:
PMC4959028.
Article
29. Loggia ML, Chonde DB, Akeju O, Arabasz G, Catana C, Edwards RR, et al. 2015; Evidence for brain glial activation in chronic pain patients. Brain. 138(Pt 3):604–15. DOI:
10.1093/brain/awu377. PMID:
25582579. PMCID:
PMC4339770.
Article
31. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, et al. 2004; Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 364:1779–85. DOI:
10.1016/S0140-6736(04)17401-1. PMID:
15541451. PMCID:
PMC4321997.
Article
32. Oka T, Aou S, Hori T. 1994; Intracerebroventricular injection of interleukin-1 beta enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats. Brain Res. 656:236–44. DOI:
10.1016/0006-8993(94)91466-4. PMID:
7820583.
33. Hahm ET, Kim Y, Lee JJ, Cho YW. 2011; GABAergic synaptic response and its opioidergic modulation in periaqueductal gray neurons of rats with neuropathic pain. BMC Neurosci. 12:41. DOI:
10.1186/1471-2202-12-41. PMID:
21569381. PMCID:
PMC3103474.
Article
34. Mahdian Dehkordi F, Kaboutari J, Zendehdel M, Javdani M. 2019; The antinociceptive effect of artemisinin on the inflammatory pain and role of GABAergic and opioidergic systems. Korean J Pain. 32:160–7. DOI:
10.3344/kjp.2019.32.3.160. PMID:
31257824. PMCID:
PMC6615442.
Article